A new treatment paradigm for sickle cell disease leg ulcers: Topical cannabis-based medicines

Exp Dermatol. 2021 Feb;30(2):291-293. doi: 10.1111/exd.14256. Epub 2020 Dec 15.

Authors

Vincent Maida^{1

2}, Runjie Bill Shi¹, Francesco Gabriele Tatangelo Fazzari³, Lydia-Marie Zomparelli⁴

Affiliations

¹ Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
² Division of Palliative Care, University of Toronto & Division of Supportive & Palliative Care, William Osler Health System, Toronto, ON, Canada.
³ Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
⁴ Faculty of Science, McMaster University, Hamilton, ON, Canada.

PMID: 33296532
DOI: 10.1111/exd.14256

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Cutaneous
Adult
Anemia, Sickle Cell / complications
Cannabinoid Receptor Agonists / therapeutic use*
Cannabis*
Dronabinol / analogs & derivatives*
Dronabinol / therapeutic use*
Female
Flavonoids / therapeutic use
Humans
Leg Ulcer / drug therapy*
Leg Ulcer / etiology
Phytotherapy*
Skin / metabolism
Terpenes / therapeutic use
Wound Healing / drug effects

Substances

Cannabinoid Receptor Agonists
Flavonoids
Terpenes
Dronabinol
delta(9)-tetrahydrocannabinolic acid

Associated data

ISRCTN/ISRCTN16488940